SORT-OUT III Trial Shows More Stent Thrombosis With Endeavor Than Cypher
This article was originally published in The Gray Sheet
Executive Summary
New data from Scandinavia suggests Medtronic's Endeavor zotarolimus-eluting stent may be less safe than competing drug-eluting stents